Gain Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold GANX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$1792290
Total value held
Flat
3 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $558163 | 274957 | +49911 | +22.18% |
| 2 | Ubs Group Ag | $436475 | 215012 | +215012 | NEW BUY |
| 3 | State Street Corp | $319800 | 157537 | — | Held |
| 4 | Morgan Stanley | $255723 | 125972 | -13680 | -9.80% |
| 5 | Northern Trust Corp | $196936 | 97013 | -16984 | -14.90% |
| 6 | Wells Fargo & Company/Mn | $19082 | 9400 | -1650 | -14.93% |
| 7 | Jpmorgan Chase & Co | $3366 | 1700 | — | Held |
| 8 | Barclays Plc | $2745 | 1352 | +1352 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.